Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: United States Clear all

440 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
20014
20029
200310
200412
20057
200618
200717
200817
200926
201010
201111
201216
201311
201412
201511
201617
201717
201815
201916
202017
202128
202222
202316
202423
202518
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed231
Terminated84
Recruiting48
Active, not recruiting45
Unknown status11
Withdrawn9
Suspended6
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)40
M.D. Anderson Cancer Center23
Memorial Sloan Kettering Cancer Center18
Pfizer15
Jonsson Comprehensive Cancer Center10
Emory University9
Novartis Pharmaceuticals9
Roswell Park Cancer Institute9
H. Lee Moffitt Cancer Center and Research Institute8
City of Hope Medical Center7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms440
Carcinoma, Non-Small-Cell Lung250
Breast Neoplasms108
Neoplasms80
Colorectal Neoplasms75
Ovarian Neoplasms74
Pancreatic Neoplasms66
Neoplasm Metastasis65
Melanoma57
Head and Neck Neoplasms54

Trials

Showing 1 to 25 of 440. Each trial links to its page on Pharma Observatory.

340 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.